TABLE 1

Patient Characteristics and Hepatic Removal Kinetics of Galactose and LC for 18F-FDGal in Patients with Liver Disease

Patient no.SexAge (y)Body weight (kg)EtiologyVmax (mmol/min)Km (mmol/L of blood)Vmax/Km (L of blood/min)LC
1Male6170Alcohol1.52 ± 0.400.81 ± 0.401.88 ± 0.330.18 ± 0.05
2Male6686Alcohol1.56 ± 0.170.93 ± 0.191.68 ± 0.140.23 ± 0.03
3Female6082Cryptogenic1.01 ± 0.101.00 ± 0.221.00 ± 0.130.23 ± 0.04
4Male5779Alcohol + HCV1.48 ± 0.521.41 ± 0.771.05 ± 0.250.27 ± 0.08
5Female7183Cryptogenic2.16 ± 0.271.96 ± 0.431.10 ± 0.120.29 ± 0.05
6Male5193Alcohol1.17 ± 0.220.48 ± 0.202.42 ± 0.390.18 ± 0.04
7Male6290Alcohol1.19 ± 0.180.82 ± 0.261.45 ± 0.240.22 ± 0.08
8Male6562Alcohol0.95 ± 0.111.19 ± 0.220.79 ± 0.080.28 ± 0.03
9Male4370Alcohol1.75 ± 0.350.80 ± 0.232.17 ± 0.16ND
 Mean ± SE1.18 ± 0.060.91 ± 0.081.18 ± 0.050.24 ± 0.02§
Healthy subjects
 Mean2.660.952.740.13
 Range1.81–5.340.59–2.172.16–3.130.10–0.17
  • P < 0.01 when compared with healthy subjects.

  • P < 0.001 when compared with healthy subjects.

  • § P < 0.0001 when compared with healthy subjects.

  • HCV = hepatitis C virus; ND = intrinsic clearance of 18F-FDGal could not be determined (7); mean ± SE = weighted mean ± SE of weighted mean.

  • Vmax and Km were calculated according to Equation 2; LC was calculated according to Equation 1. Individual data are given as mean ± SE of estimate. Data from healthy subjects are from Sørensen et al. (3).